Overview

Study of KD026 in Combination With Metformin in Subjects With Type 2 Diabetes Mellitus

Status:
Completed
Trial end date:
2016-03-01
Target enrollment:
Participant gender:
Summary
This study will compare the safety, tolerability and efficacy of the combination of KD026 and metformin compared to placebo and metformin on improving glycemic control in patients with type 2 diabetes mellitus.
Phase:
Phase 2
Details
Lead Sponsor:
Kadmon Corporation, LLC
Treatments:
Metformin